Effects of a beverage rich in (poly)phenols on established and novel risk markers for vascular disease in medically uncomplicated overweight or obese subjects: A four week randomized placebo-controlled trial

Atherosclerosis. 2016 Mar:246:169-76. doi: 10.1016/j.atherosclerosis.2016.01.004. Epub 2016 Jan 6.

Abstract

Objective: To determine if (poly)phenols alter cardiovascular risk factors, we assessed the potential of a high (poly)phenol beverage drink, rich in hydroxycinnamates and flavonoids, to modify vascular function in middle aged, overweight or obese subjects without medical co-morbidity in a randomized placebo controlled pilot study.

Methods: Randomly assigned active 250 ml beverages containing 361 mg of (poly)phenols and 120 mg of vitamin C or placebo (no polyphenol/vitamin C) were taken twice daily for 4 weeks. Both beverages contained 40 kcals/250 ml. The primary end-points were pulse wave velocity (PWV) and cutaneous microvascular responses to sodium nitroprusside (SNP) and acetyl choline (ACh) laser doppler iontophoresis. A range of established and novel plasma markers were also measured.

Results: Twenty subjects received active beverage and 19 placebo; all completed the study. There was no difference in cutaneous vascular response to either SNP or ACh with mean group differences (logΔ area under perfusion curve) of 0.30 (-0.65, 1.26) and 0.35 (-0.11, 0.81) respectively. Nor was there evidence of a change in log PWV with a mean group difference of 0.029 m/s (-0.042, 0.10). No significant differences were seen in plasma leptin, apolipoproteins, cystatin C, insulin, adiponectin, CRP, ICAM-1, E-Selectin or t-PA, but IL-6 increased in active versus placebo recipients (0.32 vs - 0.18 pg/ml; p=0.010).

Conclusion: There was no evidence for a short-term beneficial effect of (poly)phenol intervention on microcutaneous vascular response or pulse wave velocity, and no evidence for a benefit on established or novel risk factors in overweight or obese subjects. Our results do not support a short-term benefit of (poly)phenol supplementation on cardiometabolic risk.

Registration: Clinical Trials.gov (NCT00795834).

Keywords: Aortic augmentation index; Cardiovascular risk; Flavonoids; HydroxyCinnamates; Iontophoresis; Obesity; Overweight; Pulse wave velocity; Vascular function.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Aged
  • Biomarkers / blood
  • Coumaric Acids / administration & dosage*
  • Coumaric Acids / adverse effects
  • Female
  • Flavonoids / administration & dosage*
  • Flavonoids / adverse effects
  • Fruit and Vegetable Juices / adverse effects
  • Hemodynamics / drug effects*
  • Humans
  • Male
  • Microcirculation / drug effects
  • Middle Aged
  • Obesity / complications
  • Obesity / diagnosis
  • Obesity / drug therapy*
  • Pilot Projects
  • Polyphenols / administration & dosage*
  • Polyphenols / adverse effects
  • Pulse Wave Analysis
  • Risk Factors
  • Scotland
  • Skin / blood supply*
  • Time Factors
  • Treatment Outcome
  • Vascular Diseases / diagnosis
  • Vascular Diseases / etiology
  • Vascular Diseases / physiopathology
  • Vascular Diseases / prevention & control*
  • Vascular Resistance / drug effects
  • Vascular Stiffness / drug effects
  • Vasodilation / drug effects

Substances

  • Biomarkers
  • Coumaric Acids
  • Flavonoids
  • Polyphenols

Associated data

  • ClinicalTrials.gov/NCT00795834